Search results
Results From The WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB.. The medical standard for active TB is a short course treatment involving a combination of isoniazid, rifampicin (also known as Rifampin), pyrazinamide, and ethambutol for the first two months.
Analysis of Mycobacterium tuberculosis via scanning electron microscope shows the bacteria are 2.71 ± 1.05 μm in length with an average diameter of 0.345 ± 0.029 μm. [15] The outer membrane and plasma membrane surface areas were measured to be 3.04 ± 1.33 µm 2 and 2.67 ± 1.19 µm 2, respectively.
In medicine, a side effect is an effect of the use of a medicinal drug or other treatment, usually adverse but sometimes beneficial, that is unintended. Herbal and traditional medicines also have side effects.
Tuberculosis; Other names: Phthisis, phthisis pulmonalis, consumption, great white plague: Chest X-ray of a person with advanced tuberculosis: Infection in both lungs is marked by white arrow-heads, and the formation of a cavity is marked by black arrows.
The excess solution is then wiped off and a waterproof ink mark is drawn around the injection site. The test is read 2 to 7 days later. [citation needed] Grade 0: no reaction, or induration of 3 or less puncture points; Grade 1: induration of four or more puncture points; Grade 2: induration of the six puncture points coalesce to form a circle;
Abdominal solid organs, kidneys, lymph nodes and peritoneum can be affected this way. [2] Tuberculosis is also reported to spread to the peritoneum directly from adjacently situated infected foci, such as from the fallopian tubes, adnexa, psoas abscess or secondary tuberculous spondylitis. [ 2 ]
Citing studies of TB-drug sales, the government of India now suggests the total has gone from being 2.2 million to 2.6 million people nationwide. [10] On March 24, 2019, TB Day, the Ministry of Health & Family Welfare of India notified that 2.15 million new tuberculosis patients were discovered only in 2018.
AS160 (Akt substrate of 160 kDa), which was originally known as TBC1 domain family member 4 (TBC1D4), [5] is a Rab GTPase-activating protein that in humans is encoded by the TBC1D4 gene.